
CCSI Stock Forecast & Price Target
CCSI Analyst Ratings
Bulls say
Consensus Cloud Solns is benefiting from a clear turnaround in fundamentals, with 2Q:26 revenue up 4.1% year over year to $91.4 million and adjusted EBITDA of $48.3 million, while Corporate revenue rose 9.3% and SoHo declines improved to 4.7%. Its outlook is strengthened by the shift from legacy e-faxing toward a higher-value healthcare interoperability platform, supported by the Healthcare Strategy and Solutions Group, the VA mandate, and the Harmony/AI workflow roadmap that expands upsell and retention opportunities. High margins near 53%, debt reduced to $548 million with a 2.8x debt/EBITDA ratio, and steady free cash flow of about $120 million annually suggest improving financial flexibility that can support growth investment and shareholder value.
Bears say
Consensus Cloud Solns is exposed to intense competition in secure information delivery, where even modest share loss could pressure revenue, earnings, and valuation because its fax-cloud model is a niche platform rather than a dominant franchise. Its dependence on U.S. customers also heightens sensitivity to legislation, reimbursement, and procurement shifts, while any failure to execute on product development or acquisitions could weaken growth and profitability. In addition, the business’s mission-critical handling of sensitive information makes cybersecurity breaches a material risk that could damage customer trust, trigger churn, and compress multiples.
This aggregate rating is based on analysts' research of Consensus Cloud Solutions and is not a guaranteed prediction by Public.com or investment advice.
CCSI Analyst Forecast & Price Prediction
Start investing in CCSI
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Consensus Cloud Solutions (CCSI) Forecast
CCSI Analyst Forecast & Price Prediction
Start investing in CCSI
Order type
Buy in
Order amount
Est. shares
0 shares